Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 6c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q1 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $7.68 million versus the consensus estimate of $37.5 thousand.

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• UGI Corp. (UGI) halted on volatility, up 6%
• Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker